Efficacy of abrocitinib and dupilumab on chronic hand eczema in patients with moderate-to-severe atopic dermatitis
A prespecified exploratory analysis of the phase 3 JADE DARE study.
Bissonnette R, Shi V, Giménez-Arnau A, Crépy MN, Schuttelaar MLA, Lazariciu I, Bratt T, Selfridge A, Encinas G, Koppensteiner H
Journal of the American Academy of DermatologyIn the feed 2 Sep 2026, published online 2 Sep 2026, issue 2026 Sep 02, added to PubMed 2 Sep 2026
Topics: Atopic dermatitis & eczemaContact dermatitis
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42685907 · DOI 10.1016/j.jaad.2026.08.108